Feedback Form
 

Ntroduction - Exchange Introductions - Only proven way to promote your career

Company tagged Videos at Ntroduction - Exchange Introductions - Only proven way to promote your career

Market Connect 2011

Market Connect 2011

Uploaded by: kurtfrancis2009
Description:
The Most Dynamic Real estate company in United States today Century 21 Award. CEO and President of Award David Romero with C21 International President & CEO Rick Davidson host Market Connect 2011 with special guest speaker Simon Sinek at SeaWorld San Diego.
Tags: kurt francis San Diego Real Estate Century 21 Award Recruiting Career David Romero Rick Davidson


Market Connect 2011, @ Seaworld June 23rd @4pm to 6:30pm

Market Connect 2011, @ Seaworld June 23rd @4pm to 6:30pm

Uploaded by: kurtfrancis2009
Description:
The Most Dynamic Real Estate company in United States today Century 21 Award. CEO and President of Award David Romero with C21 International President & CEO Rick Davidson host Market Connect 2011 with special guest speaker Simon Sinek at SeaWorld San Diego on June 23rd, 2011 @ 4pm to 6:30pm
Tags: kurt francis San Diego Real Estate Century 21 Award Recruiting Career David Romero Rick Davidson imo


Dr. Charles Dinarello Co-Authors Article on AAT Research for OmniBio

Dr. Charles Dinarello Co-Authors Article on AAT Research for OmniBio

Uploaded by: OmniBioP
Description:
Dr. Charles Dinarello, Chief Scientific Officer of OmniBio, is a co-author of an article that is now available in the journal Blood, which is the premier journal of the American Society of Hematology. The paper describes the use of Alpha 1 antitrypsin (AAT) to treat mice with a lethal form of rejection of bone marrow transplantation. Mice survive the crisis with AAT treatment. OmniBio Pharmaceutical, Inc. (OTCBB: OMBP) is a clinical‐stage bio pharmaceutical company that has licensed potential new therapies currently in development for an existing FDA approved drug -- Alpha‐1 Antitrypsin (AAT). OmniBio believes that the market opportunity for the use of AAT in treating Type 1 diabetes may exceed the current market. Connect with OmniBio: News: OmniBioPharma.com Facebook goo.gl LinkedIn: goo.gl Visit OmniBioPharma.com for SEC filings and additional information. Please refer to Safe Harbor statement at the end of the video. OmniBio, part of the WestMountain Asset Management portfolio, is evaluating AAT for the treatment of several diseases, including Type 1 diabetes, bone marrow transplantation complications (also known as graft versus host disease or GVHD), islet transplantation, HIV, influenza and certain bacterial disorders, including anthrax exposure.. Connect with WestMountain Asset Management: Facebook: WestMountainAM.com Twitter: WestMountainAM.com LinkedIn: WestMountainAM.com Blog: WestMountainAM.com
Tags: graft host disease bone marrow transplant clinical trials alpha type 1 mellitus research cure alpha-1 antitrypsin aat jdrf juvenile children's diabetes foundation pharmaceutical industry stock investment opportunity angel investor equity development public company business finance funding portfolio venture capital startup small cap market financing healthcare health care medical westmountain West Mountain Asset Management Omni Bio James Crapo Charles Dinarello University of Colorado


Ntroduction in plain english - old

Ntroduction in plain english - old

Uploaded by: marketkonnect
Description:
How Introduction works?
Tags: Jobs Pink Slip Business Relationships Jobless Sales Staffing Startup Consultant Consulting company Staffing agency


Ntroduction in Plain English

Ntroduction in Plain English

Uploaded by: marketkonnect
Description:
What is Ntroduction?
Tags: Jobs Pink Slip Business Relationships Jobless Sales Staffing Startup Consultant Consulting company Staffing agency Company Human Resources


Type 1 Diabetes Research Update - Dr. Charles Dinarello on AAT Research at OmniBio Pharmaceutical

Type 1 Diabetes Research Update - Dr. Charles Dinarello on AAT Research at OmniBio Pharmaceutical

Uploaded by: OmniBioP
Description:
Chief Scientific Officer (CSO) for OmniBio Dr. Charles Dinarello discusses Alpha-1 Antitrypsin (AAT) research and it's potential as a therapy for Type 1 diabetes. He is also a Professor of Medicine and Immunology at the University of Colorado Denver who has published over 700 original research articles on cytokines, particularly interleukin‐1 (IL‐1) and tumor necrosis factor, and is considered a "founding father" of cytokine biology. OmniBio Pharmaceutical, Inc. (OTCBB: OMBP) is a clinical‐stage bio pharmaceutical company that has licensed potential new therapies currently in development for an existing FDA approved drug -- Alpha‐1 Antitrypsin (AAT). OmniBio believes that the market opportunity for the use of AAT in treating Type 1 diabetes may exceed the current market. Connect with OmniBio: News: OmniBioPharma.com Facebook goo.gl LinkedIn: goo.gl Visit OmniBioPharma.com for SEC filings and additional information. Please refer to Safe Harbor statement at the end of the video. OmniBio, part of the WestMountain Asset Management portfolio, is evaluating AAT for the treatment of several diseases, including Type 1 diabetes, bone marrow transplantation complications (also known as graft versus host disease or GVHD), islet transplantation, HIV, influenza and certain bacterial disorders, including anthrax exposure.. Connect with WestMountain Asset Management: Facebook: WestMountainAM.com Twitter: WestMountainAM.com LinkedIn: WestMountainAM.com Blog: WestMountainAM.com
Tags: graft host disease bone marrow transplant clinical trials alpha type 1 mellitus research cure alpha-1 antitrypsin aat jdrf juvenile children's diabetes foundation pharmaceutical industry stock investment opportunity angel investor equity development public company business finance funding portfolio venture capital startup small cap market financing healthcare health care medical westmountain West Mountain Asset Management Omni Bio James Crapo Charles Dinarello University of Colorado


Keynote Speaker: David Scott • Presented by SPEAK Inc.

Keynote Speaker: David Scott • Presented by SPEAK Inc.

Uploaded by: speakinc
Description:
avid Meerman Scott`s book The New Rules of Marketing and PR opened people`s eyes to the new realities of marketing and public relations on the Web. Six months on the BusinessWeek bestseller list and published in 26 languages from Bulgarian to Vietnamese, New Rules, now in its second edition, is a modern business classic. Scott`s popular blog and hundreds of speaking engagements around the world give him a singular perspective on how businesses are implementing new strategies to reach buyers. His newest book Real-Time Marketing and PR: How to Instantly Engage Your Market, Connect with Customers, and Create Products that Grow Your Business Now was released in November 2010. It achieved #2 on the Wall Street Journal bestseller list and #3 on the USA Today bestseller list. He is also the co-author (with Brian Halligan) of the hit book Marketing Lessons from the Grateful Dead: What Every Business Can Learn from the Most Iconic Band in History and wrote three other books including World Wide Rave. His blog - Web Ink Now - is ranked by AdAge Power 150 as a top worldwide marketing blog. He is a recovering VP of marketing for two publicly traded technology companies and was also Asia marketing director for Knight-Ridder, at the time one of the world`s largest newspaper and electronic information companies. David has lived and worked in New York, Tokyo, and Hong Kong. He currently lives in the Boston area and writes for Huffington Post. www.speakinc.com Book David Scott as akeynote ...
Tags: David Scott keynote speaker speaker bureau speak


Type 1 Diabetes Research - OmniBio CEO Dr. James Crapo

Type 1 Diabetes Research - OmniBio CEO Dr. James Crapo

Uploaded by: OmniBioP
Description:
OmniBio CEO Dr. James Crapo talks about the important research taking place with Alpha-1 Antitrypsin (AAT). This safe and powerful molecule is being used in trials for type 1 diabetes and Graph vs. Host disease (GVH). OmniBio Pharmaceutical, Inc. (OTCBB: OMBP) is a clinical‐stage bio pharmaceutical company that has licensed potential new therapies currently in development for an existing FDA approved drug -- Alpha‐1 Antitrypsin (AAT). OmniBio believes that the market opportunity for the use of AAT in treating Type 1 diabetes may exceed the current market. Connect with OmniBio: News: OmniBioPharma.com Facebook goo.gl LinkedIn: goo.gl Visit OmniBioPharma.com for SEC filings and additional information. Please refer to Safe Harbor statement at the end of the video. OmniBio, part of the WestMountain Asset Management portfolio, is evaluating AAT for the treatment of several diseases, including Type 1 diabetes, bone marrow transplantation complications (also known as graft versus host disease or GVHD), islet transplantation, HIV, influenza and certain bacterial disorders, including anthrax exposure.. Connect with WestMountain Asset Management: Facebook: WestMountainAM.com Twitter: WestMountainAM.com LinkedIn: WestMountainAM.com Blog: WestMountainAM.com
Tags: graft host disease bone marrow transplant clinical trials alpha type 1 mellitus research cure alpha-1 antitrypsin aat jdrf juvenile children's diabetes foundation pharmaceutical industry stock investment opportunity angel investor equity development public company business finance funding portfolio venture capital startup small cap market financing healthcare health care medical westmountain West Mountain Asset Management Omni Bio James Crapo Charles Dinarello University of Colorado


Archos 70 Internet Tablet Gaming & Android Market

Archos 70 Internet Tablet Gaming & Android Market

Uploaded by: davomrmac
Description:
In this video I take a more in depth look at gaming on the Archos 70 Internet Tablet. This is then followed by a look at the supplied AppsLib app and Android Market which I installed to the device via an apk file. More Archos 70 videos on the Geekanoids Channel soon. Useful Links Manufactured by: www.archos.com Supplied by: www.amp3.co.uk Sponsor: www.mymemory.com YouTube Channel: www.youtube.com Website: www.geekanoids.co.uk Twitter: www.twitter.com
Tags: Archos 70 Internet Tablet Gaming Angry Birds Android Market davomrmac geekanoids


Panasonic VIERA - VIERA Connect Market Operating Guide

Panasonic VIERA - VIERA Connect Market Operating Guide

Uploaded by: PanasonicVIERAglobal
Description:
VIERA Connect Apps and optional accessories can be easily purchased from VIERA Connect Market right on the VIERA screen. The operating procedure is shown here. *This is the European version. Check out this site for details -- panasonic.net VIERA Global Site panasonic.net
Tags: VIERA Connect Market Operating Guide




Navigate 1
Olark Livehelp
  NtroNetworking Sign-up for Newsletter What's Happening on Ntroduction? Affiliates  
  Videos Reward Calculator Get 'introduce me' button FAQ  
  Terms of Conditions Escrow terms and conditions Support Contact us